Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

NCT06775821 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-15

No results posted yet for this study

Summary

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.

Conditions

  • Abdominal Aortic Aneurysm
  • Primary Lung Cancer
  • Prevalence

Interventions

DEVICE

Ultrasound or CT of the abdominal aorta

Patient underwent ultrasound or CT of the abdominal aorta

Sponsors & Collaborators

  • The Third Affiliated Hospital of Kunming Medical University

    collaborator UNKNOWN
  • Kunming Medical University

    collaborator OTHER
  • First Affiliated Hospital of Kunming Medical University

    lead OTHER

Principal Investigators

  • Xu-Dong Xiang, MPhil · The Third Affiliated Hospital of Kunming Medical University

  • Ding-yun You, Ph.D. · Kunming Medical University

  • Yun-fei Shi, MPhil · First Affiliated Hospital of Kunming Medical University

  • Gui-ming Liu, MBBS · The Third Affiliated Hospital of Kunming Medical University

  • Qing-yan Ma, MBBS · Kunming Medical University

  • Qian Zhu, MBBS · The Third Affiliated Hospital of Kunming Medical University

  • Kai-xiong Qing, ph.D. · The Third Affiliated Hospital of Kunming Medical University

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06775821 on ClinicalTrials.gov